Non-Tolerance Type-11/2 ALK Inhibitor for Cancer Treatment

Technology ID
TT-0103
Description
Innovative drug structure optimization with AI structural fitting.
Content
A bridged inhibitor to combat drug resistance Identification of the key linker joining two warheads Exceptional efficacy in xenograft mouse models
Inventors
Prof. Yong HUANG
Applicable Industries
Education, Research, and Professional Services
Biomedical, Healthcare and Food
Potential Application
Artificial Intelligent
Drug Discovery
Technology Focus
Medical and Biotechnology
TRL
3
IP Status
Patent Pending